Who
Sheila A. Denton
SVP, Gen. Counsel & Corp. Sec.
Company insider
Files Form 4 as: SVP, Gen. Counsel & Corp. Sec., MiniMed Group; EVP & General Counsel, Incyte.
In numbers
- Trades disclosed
- 54
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $2.1M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Oct 2023
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | MMED MiniMed GroupMedical Devices | SEC FORM 4 Code A | —58,939 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code M | —278 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code M | $18K278 at $64.25 | filing |
| 17 Nov 2025filed 19 Nov 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $29K278 at $104.36 | filing |
| 4 Nov 2025filed 6 Nov 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code M | —598 at $0.00 | filing |
| 4 Nov 2025filed 6 Nov 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code M | $35K598 at $58.06 | filing |
| 4 Nov 2025filed 6 Nov 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $61K598 at $101.36 | filing |
| 15 Oct 2025filed 17 Oct 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code M | —277 at $0.00 | filing |
| 15 Oct 2025filed 17 Oct 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code M | $18K277 at $64.25 | filing |
| 15 Oct 2025filed 17 Oct 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $24K277 at $85.13 | filing |
| 3 Oct 2025filed 6 Oct 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $299K3,501 at $85.54 | filing |
| 2 Oct 2025filed 6 Oct 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code M | —599 at $0.00 | filing |
| 2 Oct 2025filed 6 Oct 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code M | $35K599 at $58.06 | filing |
| 2 Oct 2025filed 6 Oct 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $53K599 at $87.65 | filing |
| 2 Oct 2025filed 6 Oct 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $270K3,130 at $86.28 | filing |
| 16 Sep 2025filed 18 Sep 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code M | —278 at $0.00 | filing |
| 16 Sep 2025filed 18 Sep 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code M | $18K278 at $64.25 | filing |
| 16 Sep 2025filed 18 Sep 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $23K278 at $83.15 | filing |
| 2 Sep 2025filed 4 Sep 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code M | —598 at $0.00 | filing |
| 2 Sep 2025filed 4 Sep 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code M | $35K598 at $58.06 | filing |
News
Comparing Madrigal Pharmaceuticals (NASDAQ:MDGL) and Incyte (NASDAQ:INCY)INCY · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Sheila A. Denton; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.